- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 25th, 2007
The company is engineering nanoscale particles that will deliver two drugs directly to the site of a tumor: One drug will shut down the blood vessels that feed the tumor while the other will deliver chemotherapy over a sustained period. By custom-building the package that will contain these two drugs, Tempo believes it can get the drugs to the right place -- and reduce side effects.
"Nanotechnology," Crane said, "has the potential to redefine drug therapy over the next five to 10 years."
|Related News Press|
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
One step closer to a single-molecule device: Columbia Engineering researchers first to create a single-molecule diode -- the ultimate in miniaturization for electronic devices -- with potential for real-world applications May 25th, 2015